Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Boxer

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
British Journal of Cancer|February 1, 1994
The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodiesY Olabiran, J A Ledermann, N J Marston, et al.
Cancer|March 6, 2002
A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selectionAiden A Flynn, Alan J Green, R Barbara Pedley, et al.
The Journal of Biological Chemistry|April 8, 2003
Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic beta-cellsPurevsuren Jambal, Sara Masterson, Albina Nesterova, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 31, 1990
Serial measurements of Ca antigen in sera from patients with advanced malignant breast diseaseF Searle, S M Chantler, A B Goodall, et al.
Journal of Medical Genetics|February 1, 1989
Prenatal exclusion testing for Huntington's disease: a problem of too much informationF A Millan, A Curtis, M Mennie, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2005
Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude miceEthaar El-Emir, Geoffrey M Boxer, Ingrid A Petrie, et al.
International Journal of Cancer|April 1, 1994
Production and tumour-binding characterization of a chimeric anti-CEA Fab expressed in Escherichia coliK A Chester, L Robson, P A Keep, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 18, 2003
Muscle fibrillin deficiency in Marfan's syndrome myopathyW M H Behan, C Longman, R K H Petty, et al.
Nuclear Medicine and Biology|October 31, 2009
Localization of radiolabeled anti-CEA antibody in subcutaneous and intrahepatic colorectal xenografts: influence of tumor size and location within host organ on antibody uptakeJason L J Dearling, Aiden A Flynn, Uzma Qureshi, et al.
Radiation Research|January 23, 2003
The nonuniformity of antibody distribution in the kidney and its influence on dosimetryAiden A Flynn, R Barbara Pedley, Alan J Green, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
British Journal of Cancer|February 1, 1994
The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodiesY Olabiran, J A Ledermann, N J Marston, et al.
Cancer|March 6, 2002
A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selectionAiden A Flynn, Alan J Green, R Barbara Pedley, et al.
The Journal of Biological Chemistry|April 8, 2003
Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic beta-cellsPurevsuren Jambal, Sara Masterson, Albina Nesterova, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 31, 1990
Serial measurements of Ca antigen in sera from patients with advanced malignant breast diseaseF Searle, S M Chantler, A B Goodall, et al.
Journal of Medical Genetics|February 1, 1989
Prenatal exclusion testing for Huntington's disease: a problem of too much informationF A Millan, A Curtis, M Mennie, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2005
Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude miceEthaar El-Emir, Geoffrey M Boxer, Ingrid A Petrie, et al.
International Journal of Cancer|April 1, 1994
Production and tumour-binding characterization of a chimeric anti-CEA Fab expressed in Escherichia coliK A Chester, L Robson, P A Keep, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 18, 2003
Muscle fibrillin deficiency in Marfan's syndrome myopathyW M H Behan, C Longman, R K H Petty, et al.
Nuclear Medicine and Biology|October 31, 2009
Localization of radiolabeled anti-CEA antibody in subcutaneous and intrahepatic colorectal xenografts: influence of tumor size and location within host organ on antibody uptakeJason L J Dearling, Aiden A Flynn, Uzma Qureshi, et al.
Radiation Research|January 23, 2003
The nonuniformity of antibody distribution in the kidney and its influence on dosimetryAiden A Flynn, R Barbara Pedley, Alan J Green, et al.
Pageof 19